Family Physician attitudes about prescribing using a drug formulary
Tóm tắt
Drug formularies have been created by third party payers to control prescription drug usage and manage costs. Physicians try to provide the best care for their patients. This research examines family physicians' attitudes regarding prescription reimbursement criteria, prescribing and advocacy for patients experiencing reimbursement barriers. Focus groups were used to collect qualitative data on family physicians' prescribing decisions related to drug reimbursement guidelines. Forty-eight family physicians from four Ontario cities participated. Ethics approval for this study was received from the Hamilton Health Sciences/Faculty of Health Sciences Research Ethics Board at McMaster University. Four clinical scenarios were used to situate and initiate focus group discussions about prescribing decisions. Open-ended questions were used to probe physicians' experiences and attitudes and responses were audio recorded. NVivo software was used to assist in data analysis. Most physicians reported that drug reimbursement guidelines complicated their prescribing process and can require lengthy interpretation and advocacy for patients who require medication that is subject to reimbursement restrictions. Physicians do not generally see their role as being cost-containment monitors and observed that cumbersome reimbursement guidelines influence medication choice beyond the clinical needs of the patient, and produce unequal access to medication. They observed that frustration, discouragement, fatigue, and lack of appreciation can often contribute to family physicians' failure to advocate more for patients. Physicians argue cumbersome reimbursement regulations contribute to lower quality care and misuse of physicians' time increasing overall health care costs by adding unnecessary visits to family physicians, specialists, and emergency rooms.
Tài liệu tham khảo
Huskamp HA, Keating NL: The new medicare drug benefit: formularies and their potential effects on access to medications. J Gen Intern Med. 2005, 20: 662-665. 10.1007/s11606-005-0115-3.
Landon BE, Reschovsky JD, Blumenthal D: Physicians' views of formularies: implications for Medicare drug benefit design. Health Aff (Millwood). 2004, 23: 218-226. 10.1377/hlthaff.23.1.218.
Morgan SG, Agnew JD, Barer ML: Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Health Policy. 2004, 68: 299-307. 10.1016/j.healthpol.2003.10.006.
Morgan SG, Barer ML, Agnew JD: Whither seniors' pharmacare: lessons from (and for) Canada. Health Aff (Millwood). 2003, 22: 49-59. 10.1377/hlthaff.22.3.49.
Tamblyn R: The impact of pharmacotherapy policy: a case study. Can J Clin Pharmacol. 2001, 8 (Suppl A): 39A-44A.
Huttin C, Andral J: How the reimbursement system may influence physicians' decisions results from focus groups interviews in France. Health Policy. 2000, 54: 67-86. 10.1016/S0168-8510(00)00101-9.
Avery AJ, Wetzels RV, Rodgers S, O'Neill C: Do GPs working in practice with high or low prescribing costs have different views on prescribing cost issues?. Br J Gen Pract. 2000, 50: 100-104.
Schneeweiss S, Soumerai SB, Glynn RJ, Maclure M, Dormuth C, Walker AM: Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ. 2002, 166: 737-745.
Ontario Ministry of Health and Long Term Care: Ontario Drug Benefit Formulary/Comparative Drug Index No. 38. Ontario Drug Benefit Program. Ontario Drug Benefit Program No. 38. 1-30-2003. Ontario Ministry of Health and Long Term Care. 1-6-2009, [http://www.health.gov.on.ca/english/providers/program/drugs/formulary_38/ed38_0_bk.pdf]
Ontario Ministry of Health and Long Term Care & Ontario Drug Benefit Program: The Government's Plan to Reform Ontario's Drug System. 2006, Ontario Ministry of Health and Long Term Care, [http://www.health.gov.on.ca/english/providers/program/drugs/plan_reform_ods/plan_reform_ods.html]
Ontario Ministry of Health and Long Term Care & Ontario Drug Benefit Program: Ontario Drug Benefit Formulary/Comparative Drug Index (Formulary) Limited Use Modernization Strategy. 2006, 1-9. [http://www.health.gov.on.ca/english/providers/program/drugs/odbf/intervent_092705_faq.pdf]
Lexchin J: Effects of restrictive formularies in the ambulatory care setting. Am J Manag Care. 2002, 8: 69-76.
Krueger RA, Casey MA: Focus Groups: A Practical Guide for Applied Research. 2000, Thousand Oaks, Califorina: Sage Publications, 3
Raina PS, Gafni A, Bell S, Grant S, Sebaldt RJ, Fan A, Petrie A, Skilton K: Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario. Healthc Policy. 2007, 3: e128-e144.
Alexander GC, Casalino LP, Tseng CW, McFadden D, Meltzer DO: Barriers to patient-physician communication about out-of-pocket costs. Journal of General Internal Medicine. 2004, 19: 856-860. 10.1111/j.1525-1497.2004.30249.x.
Alexander GC, Casalino LP, Meltzer DO: Patient-physician communication about out-of-pocket costs. Jama-Journal of the American Medical Association. 2003, 290: 953-958. 10.1001/jama.290.7.953.
Pollara Research: Health Care in Canada Survey 2005: A National Survey of Health Care Providers, Managers, and the Public. Internet. 2005, 4-2-0006., [http://www.mediresource.com/e/pages/hcc_survey/pdf/2005_hcic.pdf]
McWhinney IR: Primary care: core values. Core values in a changing world. BMJ. 1998, 316: 1807-1809. 10.1056/NEJMp058248.
Ontario Ministry of Health and Long Term Care, Ontario Drug Benefit Program: Ontario Drug Benefit Formulary/Comparative Drug Index Edition 39. 2005, 19-20. [http://www.health.gov.on.ca/english/providers/program/drugs/formulary/ed39_0_bk.pdf]
Kasperski MJL: Implementation Strategies: Too Many Hours, Too Much Stress, Too Little Respect. 2000, Toronto, Ontario College of Family Physicians, [http://www.ocfp.on.ca/English/OCFP/Communications/Publications/]
Kravitz RL, Chang S: Promise and perils for patients and physicians. New England Journal of Medicine. 2005, 353: 2735-2739. 10.1056/NEJMp058248.
Ontario Medical Association: Ontario Medical Association Response to the Drug Strategy Review: June 2003. Internet. 2006, 10.1097/00005650-200104000-00003. 5-5-0006., [http://www.oma.org/phealth/03DSRresponse.htm]
Ontario Ministry of Health and Long-Term Care Drug System Secretariat: Right Drug, Right Person, Right Price: Improving and Governing the Provincial Drug System. 2006, Ontario Ministry of Health and Long-Term Care Drug, 1-6-2009., [http://www.health.gov.on.ca/english/public/legislation/drugs/drugsact_stakeholder.pdf]
Allan GM, Innes GD: Do family physicians know the costs of medical care? Survey in British Columbia. Can Fam Physician. 2004, 50: 263-270. 10.1097/01.mlr.0000170002.90751.1a.
Anis AH, Guh D, Wang X: A dog's breakfast: prescription drug coverage varies widely across Canada. Med Care. 2001, 39: 315-326. 10.1371/journal.pmed.0040283.
Laupacis A: Incorporating economic evaluations into decision-making: the Ontario experience. Med Care. 2005, 43: 15-19. 10.1097/01.mlr.0000170002.90751.1a.
Allan GM, Lexchin J, Wiebe N: Physician awareness of drug cost: a systematic review. PLoS Med. 2007, 4: e283-10.1371/journal.pmed.0040283.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2296/10/69/prepub